BELLEVUE, WA, Viome Life Sciences, a longevity company committed to individualized health solutions, announced a $86.5 million Oversubscribed Series C funding round.
Viome Life Sciences, a longevity company committed to individualized health solutions, announced an $86.5 million Oversubscribed Series C funding round with participation from Khosla Ventures, Bold Capital, and WRG Ventures.
(c) by Massinvestor, Inc. For contact info, please check out our
about page.
